Biophysical basis of tight junction barrier modulation by a pan-claudin-binding molecule

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Medicine

Background:

• Claudins are essential membrane proteins forming tight junctions, crucial for tissue barrier integrity.
• Tight junctions regulate paracellular transport, making claudin-binding molecules attractive for therapeutic applications.
• Developing claudin-binding molecules is challenging due to their physicochemical properties and small targetable surfaces.

Purpose of the Study:

• To develop and characterize a novel synthetic antibody fragment (sFab) with broad claudin-binding capabilities.
• To investigate the potential of this sFab for modulating tight junction permeability.
• To assess the utility of the sFab as a tool for both basic research and therapeutic development.

Main Methods:

• Development of a synthetic antibody fragment (sFab).
• Affinity-based binding assays to determine claudin subtype specificity and affinity.
• Application of the sFab to a model intestinal epithelium to assess its effect on paracellular barriers.

Main Results:

• The developed sFab exhibits nanomolar affinity for 10 claudin subtypes and other related family members.
• The sFab specifically targets the extracellular surfaces of claudins, not other tight junction proteins.
• Application of the sFab to a model intestinal epithelium successfully opened paracellular barriers.

Conclusions:

• A novel pan-claudin-binding synthetic antibody fragment (sFab) has been developed.
• This sFab effectively targets claudins and modulates tight junction permeability.
• The sFab shows promise as a versatile tool for in vitro/in vivo research and therapeutic strategies targeting tight junction-associated diseases.